# Otsuka Pharmaceutical Factory and ICU Medical establish IV solution joint venture

Otsuka Pharmaceutical Factory America (OPFA) will acquire a 60% stake in a new IV solution company formed with ICU Medical, which will transfer its IV solution business to the new entity. The agreement was signed on November 12, 2024, and operations are expected to begin in early Q2 2025.

- Type: Acquisition
- Announced: 2024-11-13
- Where: United States
- Status: announced
- Products: IV solutions
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ICU Medical](https://endata.com/companies/891.md) (target)
- [Otsuka Pharmaceutical Factory](https://endata.com/companies/26482.md) (acquirer)

## Sources

- [otsukakj.jp](https://www.otsukakj.jp/en/news_release/20241113.html), 2024-11-13: "OPFA will obtain 60% shares of the new company, which will then become a subsidiary of OPFA, inaugurating OPFA's foray into the North American IV solution business."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.